MIRERC 072/2025: Prevalence and Genotype Distribution of High-risk HPV Among Women in Ghana and Kenya

Authors

  • Dr. Frank Onyambu Meru University of Science and Technology
  • Yaw Bediako, PhD Yemaachi Biotech
  • Eliza Mari Kwesi-Maliepaard Yemaachi Biotech
  • Dr. Emmanuella Amoako Yemaachi Biotech
  • Nasteha Issack Yemaachi Biotech
  • Celestine Kemunto Yemaachi Biotech

Abstract

Abstract

Background: The burden of cervical cancer is highest in Africa. HPV infection is the major cause of cervical cancer. There are over 200 different HPV genotypes, with 15 considered (potential) high-risk genotypes for developing cancer. Due to lack of systematic screening programs in most African countries there is limited data available on which HPV-genotypes are most prevalent in the population.

Methods: We want to analyze a database of HPV-genotyping data from cervical samples submitted for diagnostic HPV-genotype testing. We have data available from HPV genotyping in Ghana (n = 1451) and Kenya (n = 46). The data will be analyzed to assess the prevalence of HPV infection in this database and to determine the distribution of high-risk HPV genotypes.

Expected outcome and implications: We expect that the outcomes from our analysis of the HPV genotyping data will contribute to a better understanding of HPV infection in African women. This will also help to inform decision making on HPV screening and HPV vaccination strategies.

Additional Files

Published

2025-09-22

How to Cite

Onyambu, D. F., Yaw Bediako, PhD, Eliza Mari Kwesi-Maliepaard, Dr. Emmanuella Amoako, Nasteha Issack, & Celestine Kemunto. (2025). MIRERC 072/2025: Prevalence and Genotype Distribution of High-risk HPV Among Women in Ghana and Kenya. MUST Institutional Research Ethics Review Committee (MIRERC), 3. Retrieved from http://41.89.229.17/index.php/MIRERC/article/view/58

Issue

Vol. 3 (2025): MIRERC Approval Letters

Section

Health Sciences